Nucleosides - RNA / BOC Sciences

8-Aminoguanosine

Description: A potent inhibitor of purine nucleoside phosphorylase.

CAT: BRP-01917

CAS: 3868-32-4

MF: C10H14N6O5

MF: 298.26

Purity: 98%

Appearance: Off-White to Tan Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C, under inert atmosphere

Density: 2.44±0.1 g/cm3

Melting Point: >240 °C (dec.)

InChIKey: FNXPTCITVCRFRK-UMMCILCDSA-N

Solubility: Soluble in Hot DMSO, Hot Water

CanonicalSMILES: C(C1C(C(C(O1)N2C3=C(C(=O)NC(=N3)N)N=C2N)O)O)O

IUPAC Name: 2,8-diamino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one

InChI: InChI=1S/C10H14N6O5/c11-9-14-6-3(7(20)15-9)13-10(12)16(6)8-5(19)4(18)2(1-17)21-8/h2,4-5,8,17-19H,1H2,(H2,12,13)(H3,11,14,15,20)/t2-,4-,5-,8-/m1/s1

Synonyms: Inosine, 2,8-diamino-; NSC 90390; 2,8-Diaminoinosine; 2,8-diamino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,9-dihydro-6H-purin-6-one

6-Chloroguanine riboside

Description: 6-Chloroguanine riboside is a novel inhibitor of endogenous protein degradation. 6-Chloroguanine riboside is a modified nucleoside with a chlorine atom at the 6-position of the guanine base. It is used in biochemical and pharmacological research to study nucleic acid structure and function, mutagenesis, and potential therapeutic applications, including antiviral and anticancer activities.

CAT: BRP-01919

CAS: 2004-07-1

MF: C10H12ClN5O4

MF: 301.69

Purity: ≥97% by HPLC

Appearance: White Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20°C

Density: 2.19 g/cm3

Melting Point: 171-172 °C (dec.)

Boiling Point: 729.9±70.0 °C at 760 mmHg

InChIKey: TXWHPSZYRUHEGT-UUOKFMHZSA-N

Solubility: Soluble in DMSO, Methanol

CanonicalSMILES: C1=NC2=C(N1C3C(C(C(O3)CO)O)O)N=C(N=C2Cl)N

IUPAC Name: (2R,3R,4S,5R)-2-(2-amino-6-chloropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

InChI: InChI=1S/C10H12ClN5O4/c11-7-4-8(15-10(12)14-7)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,14,15)/t3-,5-,6-,9-/m1/s1

Synonyms: 6-Chloroguanosine; 2-Amino-6-chloro-9-(β-D-ribofuranosyl)-purine; 6-Chloro-9-β-D-ribofuranosyl-9H-purin-2-amine; 2-Amino-6-chloropurine Ribonucleoside; 2-Amino-6-chloropurine Riboside; NSC 44586; (2R,3R,4S,5R)-2-(2-Amino-6-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol

(E)-N'-(9-((2R,3R,4R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-((tert-butyldimethylsilyl)oxy)-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-N,N-dimethylformimidamide

Description: (E)-N'-(9-((2R,3R,4R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-((tert-butyldimethylsilyl)oxy)-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-N,N-dimethylformimidamide, a novel molecule with potential applications in cancer therapy, has been shown to act by selectively inhibiting certain proteins critical to cancer cell proliferation and survival. Studies performed in preclinical models demonstrated promising results, and efforts to further develop this compound are currently underway. Defining a precise mechanism of action will require more detailed studies of this complex therapeutic candidate.

CAT: BRP-01921

MF: C40H50N6O7Si

MF: 754.95

Purity: 98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.2±0.1 g/cm3

InChIKey: QLIITSYHYKRUSO-NZMSPFHGSA-N

CanonicalSMILES: CC(C)(C)[Si](C)(C)OC1C(C(OC1N2C=NC3=C2N=C(NC3=O)N=CN(C)C)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O

IUPAC Name: N'-[9-[(2R,3R,4R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-[tert-butyl(dimethyl)silyl]oxy-4-hydroxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-N,N-dimethylmethanimidamide

InChI: InChI=1S/C40H50N6O7Si/c1-39(2,3)54(8,9)53-34-33(47)31(52-37(34)46-25-41-32-35(46)43-38(44-36(32)48)42-24-45(4)5)23-51-40(26-13-11-10-12-14-26,27-15-19-29(49-6)20-16-27)28-17-21-30(50-7)22-18-28/h10-22,24-25,31,33-34,37,47H,23H2,1-9H3,(H,43,44,48)/b42-24+/t31?,33-,34-,37-/m1/s1

Synonyms: Guanosine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-N-[(dimethylamino)methylene]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]-, (4ξ)-; (4ξ)-5'-O-[Bis(4-methoxyphenyl)(phenyl)methyl]-N-[(dimethylamino)methylen]-2'-O-[dimethyl(2-methyl-2-propanyl)silyl]guanosine

Related CAS: 126922-61-0 (2'-O-(t-Butyldimethylsilyl)-N-(dimethylaminomethylene)-5'-O-(4,4'-dimethoxytrityl)guanosine)

2'-O-(t-Butyldimethylsilyl)-N-(dimethylaminomethylene)-5'-O-(4,4'-dimethoxytrityl)guanosine

Description: 2'-O-(t-Butyldimethylsilyl)-N-(dimethylaminomethylene)-5'-O-(4,4'-dimethoxytrityl)guanosine is a crucial intermediate in the chemical synthesis of RNA oligonucleotides. The protecting groups ensure the correct assembly of RNA sequences by preventing unwanted side reactions. This compound is widely used in biochemical research and therapeutic development, particularly in studies involving RNA structure and function.

CAT: BRP-01922

CAS: 126922-61-0

MF: C40H50N6O7Si

MF: 754.95

Purity: 95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Density: 1.23±0.1 g/cm3

InChIKey: QLIITSYHYKRUSO-SPBWOXKUSA-N

CanonicalSMILES: CC(C)(C)[Si](C)(C)OC1C(C(OC1N2C=NC3=C2N=C(NC3=O)N=CN(C)C)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O

IUPAC Name: N'-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-[tert-butyl(dimethyl)silyl]oxy-4-hydroxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-N,N-dimethylmethanimidamide

Synonyms: 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-N-[(dimethylamino)methylene]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]guanosine; 5'-O-DMT-2'-O-TBDMS-N2-dimethylformamidine-guanosine; 5'-O-DMT-2'-O-TBDMS-G(DMF)

5'-Acetyl-2',3'-isopropylidene Adenosine

Description: 5'-Acetyl-2',3'-isopropylidene Adenosine, a highly advanced and multifunctional bioactive compound, plays a pivotal role in the realm of cutting-edge biomedical research.

CAT: BRP-01923

CAS: 15888-38-7

MF: C15H19N5O5

MF: 349.34

Purity: 97%

Appearance: White Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20°C

Density: 1.68±0.1 g/cm3

Melting Point: 170-172 °C

Boiling Point: 562.2±60.0 °C at 760 mmHg

InChIKey: AGPPMENETHBDES-IDTAVKCVSA-N

Solubility: Soluble in Chloroform (Slightly), Methanol (Slightly)

CanonicalSMILES: CC(=O)OCC1C2C(C(O1)N3C=NC4=C3N=CN=C4N)OC(O2)(C)C

IUPAC Name: [(3aR,4R,6R,6aR)-4-(6-aminopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl acetate

InChI: InChI=1S/C15H19N5O5/c1-7(21)22-4-8-10-11(25-15(2,3)24-10)14(23-8)20-6-19-9-12(16)17-5-18-13(9)20/h5-6,8,10-11,14H,4H2,1-3H3,(H2,16,17,18)/t8-,10-,11-,14-/m1/s1

Synonyms: 5'-O-Acetyl-2',3'-O-isopropylideneadenosine; 2',3'-O-Isopropylidene-5'-O-acetyladenosine; 2',3'-O-(1-Methylethylidene)adenosine 5'-Acetate; NSC 90373; Adenosine, 2',3'-O-(1-methylethylidene)-, 5'-acetate; Adenosine, 2',3'-O-isopropylidene-, 5'-acetate; 5'-Acetyl-2',3'-isopropylideneadenosine

N6-p-Sulfophenyladenosine

Description: N6-p-Sulfophenyladenosine is a modified adenosine derivative used extensively in biochemical and pharmacological research. Its unique modification at the N6 position allows for the detailed study of adenosine receptor interactions, signal transduction pathways, and the development of potential therapeutic agents targeting adenosine-related pathways. The addition of the sulfophenyl group can significantly influence its binding properties and biological activities, making it a valuable tool in various research applications.

CAT: BRP-01924

CAS: 143668-15-9

MF: C16H17N5O7S

MF: 423.40

Purity: 98%

Appearance: Off-white solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.91±0.1 g/cm3

InChIKey: ZUEJJBKBTNSMGJ-XNIJJKJLSA-N

CanonicalSMILES: C1=CC(=CC=C1NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O)S(=O)(=O)O

IUPAC Name: 4-[[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]amino]benzenesulfonic acid

InChI: InChI=1S/C16H17N5O7S/c22-5-10-12(23)13(24)16(28-10)21-7-19-11-14(17-6-18-15(11)21)20-8-1-3-9(4-2-8)29(25,26)27/h1-4,6-7,10,12-13,16,22-24H,5H2,(H,17,18,20)(H,25,26,27)/t10-,12-,13-,16-/m1/s1

Synonyms: Benzenesulfonic acid, 4-[(9-β-D-ribofuranosyl-9H-purin-6-yl)amino]-; N6-(p-Sulfophenyl)adenosine; 4-[(9-β-D-Ribofuranosyl-9H-purin-6-yl)amino]benzenesulfonic acid; N-(p-Sulfophenyl)adenosine

Related CAS: 1349749-05-8 (monosodium salt) ; 143668-16-0 (triethylamine salt (1:1))

6-Chloropurine Riboside

Description: 6-Chloropurine Riboside is an adenosine deaminase substrate. 6-Chloropurine Riboside is a modified nucleoside where a chlorine atom is attached to the 6-position of the purine base. It is used in biochemical research to study nucleic acid structure and function, and to investigate nucleic acid interactions. Additionally, it serves as a precursor in the synthesis of other modified nucleosides and nucleotides for therapeutic and diagnostic applications.

CAT: BRP-01926

CAS: 5399-87-1

MF: C10H11ClN4O4

MF: 286.67

Purity: ≥98% by HPLC

Appearance: White to beige solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

Density: 2.03±0.1 g/cm3

Melting Point: 180-182 °C

Boiling Point: 614.8±65.0 °C at 760 mmHg

InChIKey: XHRJGHCQQPETRH-KQYNXXCUSA-N

Solubility: Soluble in DMSO (Sparingly, Heated), Methanol (Slightly, Heated), Water (Slightly, Heated)

CanonicalSMILES: C1=NC2=C(C(=N1)Cl)N=CN2C3C(C(C(O3)CO)O)O

IUPAC Name: (2R,3R,4S,5R)-2-(6-chloropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

InChI: InChI=1S/C10H11ClN4O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2/t4-,6-,7-,10-/m1/s1

Synonyms: 6-Chloro Inosine; 6-Chloro-9-(beta-D-ribofuranosyl)purine; 6-chloroinosine; 6-Chloropurine-9-β-D-ribofuranoside; 6-Chloro-6-deaminoadenosine; 6-Chloro-9-β-D-ribofuranosyl-9H-purine; 6-Chloro-9-β-D-ribofuranosylpurine; 6-Chloronebularine; 6-Chloropurine-D-riboside; 6-Chloropurinosine; 9-(β-D-Ribofuranosyl)-6-chloropurine; NSC 4910; Chloropurine riboside

2,6-Dichloropurine-9-β-D-riboside

Description: 2,6-Dichloropurine riboside is a valuable tool in biochemical, pharmacological, and chemical biology research. Its modified structure allows scientists to study the effects of chlorine substitution on nucleotide function, enzyme interactions, and potential therapeutic applications in antiviral and anticancer treatments. This compound provides insights into the role of modified nucleosides in various biological processes and the development of novel therapeutic agents.

CAT: BRP-01927

CAS: 13276-52-3

MF: C10H10Cl2N4O4

MF: 321.12

Purity: 97%

Appearance: White to Off-White Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20°C

Density: 2.14±0.1 g/cm3(Predicted)

Melting Point: >190°C (dec)

Boiling Point: 542.2±60.0 °C(Predicted)

InChIKey: HJXWZGVMHDPCRS-UUOKFMHZSA-N

Solubility: Soluble in Methanol, Water

CanonicalSMILES: C1=NC2=C(N1C3C(C(C(O3)CO)O)O)N=C(N=C2Cl)Cl

IUPAC Name: (2R,3R,4S,5R)-2-(2,6-dichloropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

InChI: InChI=1S/C10H10Cl2N4O4/c11-7-4-8(15-10(12)14-7)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2/t3-,5-,6-,9-/m1/s1

Synonyms: 2,6-Dichloropurine riboside; (2R,3R,4S,5R)-2-(2,6-Dichloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; 2,6-Dichloro-9-β-D-ribofuranosyl-9H-purine; Purine, 2,6-dichloro-9-β-D-ribofuranosyl-

4-Chloro-5-iodo-7-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine

Description: (2R,3R,4R,5R)-2-((benzoyloxy)methyl)-5-(4-chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)tetrahydrofuran-3,4-diyl dibenzoate, plays a critical role as an intermediary in the manufacture of cancer-fighting medications, specifically targeting breast, lung, and colorectal cancer. Its complex chemical composition and properties make it a valuable resource in the pharmaceutical industry.

CAT: BRP-01928

CAS: 480439-89-2

MF: C32H23ClIN3O7

MF: 723.90

Purity: 97%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C, stored under nitrogen

Density: 1.64±0.1 g/cm3

Boiling Point: 796.0±60.0 °C at 760 mmHg

InChIKey: WHVWNDLPQYBIGY-CTDWIVFPSA-N

CanonicalSMILES: C1=CC=C(C=C1)C(=O)OCC2C(C(C(O2)N3C=C(C4=C3N=CN=C4Cl)I)OC(=O)C5=CC=CC=C5)OC(=O)C6=CC=CC=C6

IUPAC Name: [(2R,3R,4R,5R)-3,4-dibenzoyloxy-5-(4-chloro-5-iodopyrrolo[2,3-d]pyrimidin-7-yl)oxolan-2-yl]methyl benzoate

InChI: InChI=1S/C32H23ClIN3O7/c33-27-24-22(34)16-37(28(24)36-18-35-27)29-26(44-32(40)21-14-8-3-9-15-21)25(43-31(39)20-12-6-2-7-13-20)23(42-29)17-41-30(38)19-10-4-1-5-11-19/h1-16,18,23,25-26,29H,17H2/t23-,25-,26-,29-/m1/s1

Synonyms: 7H-Pyrrolo[2,3-d]pyrimidine, 4-chloro-5-iodo-7-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-; (2R,3R,4R,5R)-2-((benzoyloxy)methyl)-5-(4-chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)tetrahydrofuran-3,4-diyl dibenzoate

6-Chloropurine-9-(2,3-isopropylidene-β-D-ribofuranoside)

Description: 6-Chloropurine-9-(2,3-isopropylidene-β-D-ribofuranoside) is a protected nucleoside analog used in chemical and biochemical research. The chlorination at the 6-position of the purine base and the isopropylidene protection of the ribose sugar allow for controlled synthesis and modification of nucleosides. This compound is valuable for studying nucleotide analog interactions, enzyme mechanisms, and potential therapeutic applications in antiviral and anticancer research.

CAT: BRP-01929

CAS: 39824-26-5

MF: C13H15ClN4O4

MF: 326.74

Purity: 98%

Appearance: Pale Yellow Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C, sealed storage, away from moisture

Density: 1.79±0.1 g/cm3 (Predicted)

Melting Point: 152-155°C

Boiling Point: 527.8±60.0°C (Predicted)

InChIKey: VDYNZOUPLVQLRV-WOUKDFQISA-N

Solubility: Soluble in Chloroform (Slightly), Dichloromethane (Slightly), Diethyl Ether (Slightly), Ethanol

CanonicalSMILES: CC1(OC2C(OC(C2O1)N3C=NC4=C3N=CN=C4Cl)CO)C

IUPAC Name: [(3aR,4R,6R,6aR)-4-(6-chloropurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methanol

InChI: InChI=1S/C13H15ClN4O4/c1-13(2)21-8-6(3-19)20-12(9(8)22-13)18-5-17-7-10(14)15-4-16-11(7)18/h4-6,8-9,12,19H,3H2,1-2H3/t6-,8-,9-,12-/m1/s1

Synonyms: 6-Chloro-9-(2',3'-di-O-isopropylidene-beta-D-ribofuranosyl)purine; 6-Chloro-9-β-D-(2,3-isopropylidene)ribofuranosylpurine; 6-Chloro-9-[2,3-O-(1-methylethylidene)-beta-D-ribofuranosyl]-9H-Purine; [(3aR,4R,6R,6aR)-4-(6-chloropurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methanol; 6-Chloro-9-(2,3-O-isopropylidene-β-D-ribofuranosyl)-9H-purine

6-Chloro-7-deazapurine-β-D-riboside

Description: 6-Chloro-7-deazapurine-β-D-riboside is an adenosine kinase inhibitor. 6-Chloro-7-deazapurine-β-D-riboside is a valuable nucleoside analog used in biochemical and pharmacological research. Its modified structure allows scientists to study the effects of chlorination and deaza modifications on nucleotide function, enzyme interactions, and potential therapeutic applications in antiviral and anticancer treatments. This compound provides insights into the role of modified nucleosides in various biological processes and the development of novel therapeutic agents.

CAT: BRP-01930

CAS: 16754-80-6

MF: C11H12ClN3O4

MF: 285.68

Purity: ≥95%

Appearance: White to Off-White Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C, stored under nitrogen

Density: 1.87±0.1 g/cm3 (Predicted)

Melting Point: 160-162°C

Boiling Point: 591.4±50.0°C (Predicted)

InChIKey: BFDDOTZWMOKUCD-UIRWVKCDSA-N

Solubility: Soluble in DMSO (Slightly), Methanol (Slightly)

CanonicalSMILES: C1=CN(C2=C1C(=NC=N2)Cl)C3C(C(C(O3)CO)O)O

IUPAC Name: (2R,3R,4S,5R)-2-(4-chloropyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)oxolane-3,4-diol

InChI: InChI=1S/C11H12ClN3O4/c12-9-5-1-2-15(10(5)14-4-13-9)11-8(18)7(17)6(3-16)19-11/h1-2,4,6-8,11,16-18H,3H2/t6-,7+,8?,11-/m1/s1

Synonyms: 6-Chloro-7-deazapurine-9-b-D-ribofuranose; 4-Chloro-7-(b-D-ribofuranosyl)-7H-pyrrolo[2.3-d]pyrimidine; 4-Chloro-7-(β-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidine; 6-Chloro-9-(β-D-ribofuranosyl)-7-deazapurine; 6-Deamino-6-chlorotubercidin; NSC 101161

6-Mercaptopurine Riboside

Description: 6-Mercaptopurine Riboside is a substrate for adenosine deaminase. 6-Mercaptopurine riboside is a nucleoside analog where the purine base is 6-mercaptopurine, which is linked to a ribose sugar. 6-Mercaptopurine riboside is a valuable compound in cancer treatment and immunosuppressive therapy due to its ability to interfere with nucleic acid synthesis and purine metabolism. Its structural similarity to normal nucleosides allows it to be incorporated into RNA and DNA, disrupting the normal function and growth of cells.

CAT: BRP-01931

CAS: 574-25-4

MF: C10H12N4O4S

MF: 284.29

Purity: 90%

Appearance: White to Beige Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C, stored under nitrogen

Density: 2.02±0.1 g/cm3

Melting Point: 198-200 °C (dec.)

Boiling Point: 714.7±70.0 °C at 760 mmHg

Application: Antimetabolites, Antineoplastic

InChIKey: NKGPJODWTZCHGF-KQYNXXCUSA-N

Solubility: Soluble in DMSO (Slightly), Methanol (Very Slightly, Heated)

CanonicalSMILES: C1=NC(=S)C2=C(N1)N(C=N2)C3C(C(C(O3)CO)O)O

IUPAC Name: 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purine-6-thione

InChI: InChI=1S/C10H12N4O4S/c15-1-4-6(16)7(17)10(18-4)14-3-13-5-8(14)11-2-12-9(5)19/h2-4,6-7,10,15-17H,1H2,(H,11,12,19)/t4-,6-,7-,10-/m1/s1

Synonyms: 6-Thioinosine; Ribosyl-6-thiopurine; 6-Thio-9-β-D-ribofuranoside; 6-Mercapto-9-β-D-ribofuranosyl-9H-purine; 6-Mercaptoinosine; 6-Mercaptopurine 9-β-D-ribofuranoside; 6-Mercaptopurine ribonucleoside; 6-MPR; 6-Thiopurine ribonucleoside; 6-Thiopurine riboside; 9-β-D-Ribofuranosyl-6-mercaptopurine; 9-β-D-Ribofuranosyl-9H-purine-6-thiol; 9-β-D-Ribofuranosyl-9H-purine-6-thione; 9-β-D-Ribofuranosylpurine-6-thiol; 9-β-D-Ribofuranosylpurine-6-thione; Chembridge 5676375; NSC 4911; Thioinosine

2,6-Dichloro-9-(2',3',5'-tri-O-acetyl-β-D-ribofuranosyl)purine

Description: 2,6-Dichloro-9-(2',3',5'-tri-O-acetyl-β-D-ribofuranosyl)purine is a valuable nucleoside analog used in chemical synthesis, biochemical, and pharmacological research. The acetylated ribose and dichlorinated purine base allow scientists to study the effects of these modifications on nucleotide function, enzyme interactions, and potential therapeutic applications in antiviral and anticancer treatments. This compound provides insights into the role of modified nucleosides in various biological processes and the development of novel therapeutic agents.

CAT: BRP-01932

CAS: 3056-18-6

MF: C16H16Cl2N4O7

MF: 447.23

Purity: ≥95%

Appearance: Off-White to Pale Yellow Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C, sealed storage, away from moisture

Density: 1.69±0.1 g/cm3 (Predicted)

Melting Point: 151-154°C

Boiling Point: 555.3±60.0°C (Predicted)

InChIKey: PYXZXWLFAMZVPY-SDBHATRESA-N

Solubility: Soluble in Chloroform (Slightly), DMSO (Slightly)

CanonicalSMILES: CC(=O)OCC1C(C(C(O1)N2C=NC3=C2N=C(N=C3Cl)Cl)OC(=O)C)OC(=O)C

IUPAC Name: [(2R,3R,4R,5R)-3,4-diacetyloxy-5-(2,6-dichloropurin-9-yl)oxolan-2-yl]methyl acetate

InChI: InChI=1S/C16H16Cl2N4O7/c1-6(23)26-4-9-11(27-7(2)24)12(28-8(3)25)15(29-9)22-5-19-10-13(17)20-16(18)21-14(10)22/h5,9,11-12,15H,4H2,1-3H3/t9-,11-,12-,15-/m1/s1

Synonyms: 9-(2,3,5-Tri-O-acetyl-beta-D-ribofuranosyl)-2,6-dichloropurine; NSC 76763; (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2,6-dichloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate; 2,6-Dichloro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-9H-purine; 2,6-Dichloro-9-(2-O,3-O,5-O-triacetyl-beta-D-ribofuranosyl)-9H-purine; 9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-2,6-dichloro-9H-purine

3',5'-Di-O-acetyl-5-bromo-2'-O-methyluridine

Description: 3',5'-Di-O-acetyl-5-bromo-2'-O-methyluridine is a remarkable biomedical compound with a resolute focus on research of notorious RNA viruses, such as hepatitis C and influenza.

CAT: BRP-01933

CAS: 1188522-81-7

MF: C14H17BrN2O8

MF: 421.20

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C, sealed storage, away from moisture

Density: 1.63±0.1 g/cm3

Melting Point: 162-164 °C

InChIKey: SRIIZANGRRSQIV-PRULPYPASA-N

CanonicalSMILES: CC(=O)OCC1C(C(C(O1)N2C=C(C(=O)NC2=O)Br)OC)OC(=O)C

IUPAC Name: [(2R,3R,4R,5R)-3-acetyloxy-5-(5-bromo-2,4-dioxopyrimidin-1-yl)-4-methoxyoxolan-2-yl]methyl acetate

InChI: InChI=1S/C14H17BrN2O8/c1-6(18)23-5-9-10(24-7(2)19)11(22-3)13(25-9)17-4-8(15)12(20)16-14(17)21/h4,9-11,13H,5H2,1-3H3,(H,16,20,21)/t9-,10-,11-,13-/m1/s1

Synonyms: ((2R,3R,4R,5R)-3-acetoxy-5-(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxytetrahydrofuran-2-yl)methyl acetate; 5-bromo-3',5'-diacetyl-2'-O-methyluridine; Uridine, 5-bromo-2'-O-methyl-, 3',5'-diacetate; 5-Bromo-2'-O-methyluridine 3',5'-diacetate

9-((3aR,4R,6R,6aR)-2,2-Dimethyl-6-((methylamino)methyl)tetrahydrofuro[3,4-d][1,3]dioxol-4-yl)-9H-purin-6-amine

Description: 9-((3aR,4R,6R,6aR)-2,2-Dimethyl-6-((methylamino)methyl)tetrahydrofuro[3,4-d][1,3]dioxol-4-yl)-9H-purin-6-amine is a formidable and effective suppressor of adenosine kinases, utilized in the amelioration of malignancies and inflammatory disorders, in addition to assorted neurological ailments rooted in adenosine signaling. Its molecular configuration bears striking resemblance to adenosine, facilitating facile assimilation into cellular paths. This enables the thwarting of intracellular effects of adenosine, leading to beneficial outcomes.

CAT: BRP-01934

CAS: 34245-49-3

MF: C14H20N6O3

MF: 320.35

Purity: 97%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C, protect from light

Density: 1.66±0.1 g/cm3

Boiling Point: 537.5±60.0 °C at 760 mmHg

InChIKey: SJXNSGJHLDXAIO-QYVSTXNMSA-N

CanonicalSMILES: CC1(OC2C(OC(C2O1)N3C=NC4=C(N=CN=C43)N)CNC)C

IUPAC Name: 9-[(3aR,4R,6R,6aR)-2,2-dimethyl-6-(methylaminomethyl)-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]purin-6-amine

InChI: InChI=1S/C14H20N6O3/c1-14(2)22-9-7(4-16-3)21-13(10(9)23-14)20-6-19-8-11(15)17-5-18-12(8)20/h5-7,9-10,13,16H,4H2,1-3H3,(H2,15,17,18)/t7-,9-,10-,13-/m1/s1

Synonyms: Adenosine, 5'-deoxy-5'-(methylamino)-2',3'-O-(1-methylethylidene)-; 5'-Deoxy-5'-(methylamino)-2',3'-O-(1-methylethylidene)adenosine; Adenosine, 5'-deoxy-2',3'-O-isopropylidene-5'-(methylamino)-

5-Chlorouridine

Description: 5-Chlorouridine is a valuable modified nucleoside used in biochemical, pharmacological, and chemical biology research. Its chlorination at the 5-position allows scientists to study the effects of halogenation on nucleotide function, RNA structure, and potential therapeutic applications. This compound provides insights into the role of modified nucleosides in various biological processes and aids in the development of novel therapeutic agents and research tools.

CAT: BRP-01935

CAS: 2880-89-9

MF: C9H11ClN2O6

MF: 278.65

Purity: ≥98% by HPLC

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.80±0.1 g/cm3

Melting Point: 210-217 °C (dec.)

InChIKey: LDCUBKKZHSYQTJ-UAKXSSHOSA-N

CanonicalSMILES: C1=C(C(=O)NC(=O)N1C2C(C(C(O2)CO)O)O)Cl

IUPAC Name: 5-chloro-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione

InChI: InChI=1S/C9H11ClN2O6/c10-3-1-12(9(17)11-7(3)16)8-6(15)5(14)4(2-13)18-8/h1,4-6,8,13-15H,2H2,(H,11,16,17)/t4-,5-,6-,8-/m1/s1

Synonyms: NSC 146433; 5-chloro-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione

3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)adenosine

Description: 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)adenosine is a novel compound utilized in the biomedical industry. It exhibits potential therapeutic effects in the treatment of diseases involving adenosine receptors such as cancer, cardiovascular disorders, and neurological conditions. Through its unique chemical structure, this compound acts as a modulator of adenosine signaling pathways, offering new avenues for drug development and research.

CAT: BRP-01937

CAS: 69304-45-6

MF: C22H39N5O5Si2

MF: 509.76

Purity: ≥95% by HPLC

Appearance: White to off-white crystalline powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.31±0.1 g/cm3

Melting Point: 143-145 °C

Boiling Point: 579.2±60.0 °C at 760 mmHg

InChIKey: KHVLHRYSOPSVJR-WGQQHEPDSA-N

CanonicalSMILES: CC(C)[Si]1(OCC2C(C(C(O2)N3C=NC4=C(N=CN=C43)N)O)O[Si](O1)(C(C)C)C(C)C)C(C)C

IUPAC Name: (6aR,8R,9R,9aS)-8-(6-aminopurin-9-yl)-2,2,4,4-tetra(propan-2-yl)-6a,8,9,9a-tetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-9-ol

InChI: InChI=1S/C22H39N5O5Si2/c1-12(2)33(13(3)4)29-9-16-19(31-34(32-33,14(5)6)15(7)8)18(28)22(30-16)27-11-26-17-20(23)24-10-25-21(17)27/h10-16,18-19,22,28H,9H2,1-8H3,(H2,23,24,25)/t16-,18-,19-,22-/m1/s1

Synonyms: 3',5'-TIPPS-D-adenosine; 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-D-adenosine; (6aR,8R,9R,9aS)-8-(6-Amino-9H-purin-9-yl)-2,2,4,4-tetraisopropyltetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-9-ol; 3',5'-O-[1,1,3,3-Tetrakis(1-methylethyl)-1,3-disiloxanediyl]adenosine

6-Chloro-2-iodopurine riboside

Description: 6-Chloro-2-iodopurine riboside, a highly potent biomedicine, exhibits noteworthy implications in addressing diverse medical conditions. Functioning as an efficacious antiviral and antineoplastic agent, it specifically targets pivotal enzymes and effectively obstructs their functionality. By virtue of its distinct molecular configuration, it showcases encouraging outcomes in combating viral infections, including herpes and influenza, as well as certain malignancies. The intricate workings of this compound render it an invaluable asset within the biomedical domain.

CAT: BRP-01938

CAS: 313477-85-9

MF: C10H10ClIN4O4

MF: 412.57

Purity: ≥95%

Appearance: White to Off-white Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8°C

Density: 2.60±0.1 g/cm3 (Predicted)

Boiling Point: 715.7±70.0 °C at 760 mmHg

InChIKey: BUXRSMOYQZICAU-UUOKFMHZSA-N

CanonicalSMILES: C1=NC2=C(N1C3C(C(C(O3)CO)O)O)N=C(N=C2Cl)I

IUPAC Name: (2R,3R,4S,5R)-2-(6-chloro-2-iodopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

InChI: InChI=1S/C10H10ClIN4O4/c11-7-4-8(15-10(12)14-7)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2/t3-,5-,6-,9-/m1/s1

Synonyms: 6-Chloro-2-iodo-9-beta-D-ribofuranosylpurine; (2S,3S,4R,5S)-2-(6-chloro-2-iodo-9H-purin-9-yl)-5-(hydroxymethyl)-tetrahydrofuran-3,4-diol; 6-Chloro-2-iodo-9-(β-D-ribofuranosyl)-9H-purine; 6-Chloro-2-iodopurineriboside; 6-Chloro-2-iodopurine-9-riboside; 6-Chloro-2-iodo-9-β-D-ribofuranosyl-9H-purine

2-Chloro-2',3'-O-isopropylideneadenosine-5'-N-ethylcarboxamide

Description: 2-Chloro-2',3'-O-isopropylideneadenosine-5'-N-ethylcarboxamide is a potent and selective adenosine receptor agonist. It is also used to prepare photoreactive 2-phenethylamine derivatives.

CAT: BRP-01939

CAS: 120225-75-4

MF: C15H19ClN6O4

MF: 382.80

Purity: 98%

Appearance: Off-white solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.77±0.1 g/cm3

Melting Point: 210-212 °C

Application: A potent selective adenosine receptor agonist.

InChIKey: CHPHKXXDQSHQKC-LOKDSWTASA-N

Solubility: Soluble in DMF, DMSO, Methanol

CanonicalSMILES: CCNC(=O)C1C2C(C(O1)N3C=NC4=C(N=C(N=C43)Cl)N)OC(O2)(C)C

IUPAC Name: (3aR,4R,6S,6aS)-4-(6-amino-2-chloropurin-9-yl)-N-ethyl-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxole-6-carboxamide

InChI: InChI=1S/C15H19ClN6O4/c1-4-18-12(23)8-7-9(26-15(2,3)25-7)13(24-8)22-5-19-6-10(17)20-14(16)21-11(6)22/h5,7-9,13H,4H2,1-3H3,(H,18,23)(H2,17,20,21)/t7-,8+,9-,13-/m1/s1

Synonyms: β-D-Ribofuranuronamide, 1-(6-amino-2-chloro-9H-purin-9-yl)-1-deoxy-N-ethyl-2,3-O-(1-methylethylidene)-; 1-(6-Amino-2-chloro-9H-purin-9-yl)-1-deoxy-N-ethyl-2,3-O-(1-methylethylidene)-β-D-ribofuranuronamide; (3aS,4S,6R,6aR)-6-(6-amino-2-chloro-9H-purin-9-yl)-N-ethyl-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxole-4-carboxamide

2-Amino-6-chloropurine-9-(2',3',5'-tri-O-acetyl)-riboside

Description: 2-Amino-6-chloropurine-9-(2',3',5'-tri-O-acetyl)-riboside, a formidable antiviral medication torments hepatitis B and C with its ability to nullify the activity of viral polymerase crucial for viral expansion. Admirably, this said substance displays an auspicious outcome in the eradication of multiple cancer strains including lymphoma and leukemia.

CAT: BRP-01940

CAS: 16321-99-6

MF: C16H18ClN5O7

MF: 427.80

Purity: ≥95%

Appearance: Pale Green Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C, sealed storage, away from moisture and light

Density: 1.70±0.1 g/cm3 (Predicted)

Melting Point: 140-142°C

Boiling Point: 637.0±65.0 °C at 760 mmHg

InChIKey: HLVGVJFVAKPFOZ-SDBHATRESA-N

Solubility: Soluble in Acetone, Chloroform, Dichloromethane

CanonicalSMILES: CC(=O)OCC1C(C(C(O1)N2C=NC3=C2N=C(N=C3Cl)N)OC(=O)C)OC(=O)C

IUPAC Name: [(2R,3R,4R,5R)-3,4-diacetyloxy-5-(2-amino-6-chloropurin-9-yl)oxolan-2-yl]methyl acetate

InChI: InChI=1S/C16H18ClN5O7/c1-6(23)26-4-9-11(27-7(2)24)12(28-8(3)25)15(29-9)22-5-19-10-13(17)20-16(18)21-14(10)22/h5,9,11-12,15H,4H2,1-3H3,(H2,18,20,21)/t9-,11-,12-,15-/m1/s1

Synonyms: 2-Amino-6-chloro-9-(2',3',5'-tri-O-acetyl-beta-D-ribofuranosyl)-9H-purine; 6-Chloro-2',3',5'-tri-O-acetylguanosine; 6-Chloro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-9H-purin-2-amine; 2',3',5'-Tri-O-acetyl-6-chloroguanosine; NSC 70388; (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2-amino-6-chloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate; 2-Amino-6-chloro-9-(2,3,5-tri-O-acetyl-beta-D-ribofuranosyl)purine; 9-(2',3',5'-Tri-O-acetyl-beta-D-ribofuranosyl)-2-amino-6-chloro-9H-purine